Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Nov;65(11):4725–4733. doi: 10.1128/iai.65.11.4725-4733.1997

Exclusion of bioactive contaminations in Streptococcus pyogenes erythrogenic toxin A preparations by recombinant expression in Escherichia coli.

U Fagin 1, U Hahn 1, J Grötzinger 1, B Fleischer 1, D Gerlach 1, F Buck 1, A Wollmer 1, H Kirchner 1, L Rink 1
PMCID: PMC175678  PMID: 9353057

Abstract

The streptococcal erythrogenic exotoxin A (SPEA) belongs to the family of bacterial superantigens and has been implicated in the pathogenesis of a toxic shock-like syndrome and scarlet fever. Concerning its biological activity, mainly T-cell-stimulatory properties, conflicting data exist. In this study, we show that most of the SPEA preparations used so far contain biologically active contaminations. Natural SPEA from the culture supernatant of Streptococcus pyogenes NY-5 and recombinant SPEA purified from the culture filtrate of S. sanguis are strongly contaminated with DNases. We show that natural SPEA induces more tumor necrosis factor alpha (TNF-alpha) than recombinant SPEA, but we also show that DNases are able to induce TNF-alpha. In commercial SPEA preparations, we identified a highly active protease, which was shown not to be SPEB. To exclude these contaminations, we overexpressed SPEA cloned in the effective high-level expression vector pIN-III-ompA2 in Escherichia coli. The expressed SPEA shows the same amino acid composition as natural SPEA, whereas functional studies reported so far were carried out with toxins containing an incorrect amino terminus. We describe the rapid purification of lipopolysaccharide-, DNase-, and protease-free SPEA in two steps from the host's periplasm and its structural characterization by circular dichroism. Our results represent for the first time the production in E. coli of recombinant SPEA with the authentic N-terminal sequence and a proven superantigenic activity. Collectively, our results indicate that immunological studies of superantigens require highly purified substances free of biologically active contaminations.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe J., Forrester J., Nakahara T., Lafferty J. A., Kotzin B. L., Leung D. Y. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol. 1991 Jun 1;146(11):3747–3750. [PubMed] [Google Scholar]
  2. Bartter T., Dascal A., Carroll K., Curley F. J. 'Toxic strep syndrome'. A manifestation of group A streptococcal infection. Arch Intern Med. 1988 Jun;148(6):1421–1424. doi: 10.1001/archinte.148.6.1421. [DOI] [PubMed] [Google Scholar]
  3. Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17(4):251–272. doi: 10.3109/10408419009105728. [DOI] [PubMed] [Google Scholar]
  4. Bohach G. A., Hauser A. R., Schlievert P. M. Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli. Infect Immun. 1988 Jun;56(6):1665–1667. doi: 10.1128/iai.56.6.1665-1667.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bohach G. A., Schlievert P. M. Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins. Mol Gen Genet. 1987 Aug;209(1):15–20. doi: 10.1007/BF00329830. [DOI] [PubMed] [Google Scholar]
  6. Braun M. A., Gerlach D., Hartwig U. F., Ozegowski J. H., Romagné F., Carrel S., Köhler W., Fleischer B. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J Immunol. 1993 Mar 15;150(6):2457–2466. [PubMed] [Google Scholar]
  7. Cunningham C. M., Barsumian E. L., Watson D. W. Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect Immun. 1976 Sep;14(3):767–775. doi: 10.1128/iai.14.3.767-775.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fleischer B., Gerardy-Schahn R., Metzroth B., Carrel S., Gerlach D., Köhler W. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction. J Immunol. 1991 Jan 1;146(1):11–17. [PubMed] [Google Scholar]
  9. Fleischer B., Gerlach D., Fuhrmann A., Schmidt K. H. Superantigens and pseudosuperantigens of gram-positive cocci. Med Microbiol Immunol. 1995 May;184(1):1–8. doi: 10.1007/BF00216783. [DOI] [PubMed] [Google Scholar]
  10. Gerlach D., Knöll H., Köhler W., Ozegowski J. H., Hríbalova V. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Sep;255(2-3):221–233. [PubMed] [Google Scholar]
  11. Gerlach D., Köhler W., Knöll H., Moravek L., Weeks C. R., Ferretti J. J. Purification and characterization of Streptococcus pyogenes erythrogenic toxin type A produced by a cloned gene in Streptococcus sanguis. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Oct;266(3-4):347–358. doi: 10.1016/s0176-6724(87)80215-8. [DOI] [PubMed] [Google Scholar]
  12. Gerlach D., Reichardt W., Fleischer B., Schmidt K. H. Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (Streptococcal proteinase). Zentralbl Bakteriol. 1994 Mar;280(4):507–514. doi: 10.1016/s0934-8840(11)80510-4. [DOI] [PubMed] [Google Scholar]
  13. Hackett S. P., Stevens D. L. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis. 1993 Jul;168(1):232–235. doi: 10.1093/infdis/168.1.232. [DOI] [PubMed] [Google Scholar]
  14. Hartwig U. F., Fleischer B. Mutations affecting MHC class II binding of the superantigen streptococcal erythrogenic toxin A. Int Immunol. 1993 Aug;5(8):869–875. doi: 10.1093/intimm/5.8.869. [DOI] [PubMed] [Google Scholar]
  15. Hartwig U. F., Gerlach D., Fleischer B. Major histocompatibility complex class II binding site for streptococcal pyrogenic (erythrogenic) toxin A. Med Microbiol Immunol. 1994 Nov;183(5):257–264. doi: 10.1007/BF00198459. [DOI] [PubMed] [Google Scholar]
  16. Holm S. E., Norrby A., Bergholm A. M., Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis. 1992 Jul;166(1):31–37. doi: 10.1093/infdis/166.1.31. [DOI] [PubMed] [Google Scholar]
  17. Imanishi K., Igarashi H., Uchiyama T. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells. J Immunol. 1990 Nov 15;145(10):3170–3176. [PubMed] [Google Scholar]
  18. Imanishi K., Igarashi H., Uchiyama T. Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B. Infect Immun. 1992 Dec;60(12):5025–5029. doi: 10.1128/iai.60.12.5025-5029.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Janeway C. A., Jr Selective elements for the V beta region of the T cell receptor: Mls and the bacterial toxic mitogens. Adv Immunol. 1991;50:1–53. doi: 10.1016/s0065-2776(08)60821-4. [DOI] [PubMed] [Google Scholar]
  20. Johnson L. P., L'Italien J. J., Schlievert P. M. Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B. Mol Gen Genet. 1986 May;203(2):354–356. doi: 10.1007/BF00333979. [DOI] [PubMed] [Google Scholar]
  21. Johnson L. P., Schlievert P. M. Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A. Mol Gen Genet. 1984;194(1-2):52–56. doi: 10.1007/BF00383496. [DOI] [PubMed] [Google Scholar]
  22. KUNITZ M. Crystalline desoxyribonuclease; isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity. J Gen Physiol. 1950 Mar;33(4):349–362. doi: 10.1085/jgp.33.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kamezawa Y., Nakahara T. Purification and characterization of streptococcal erythrogenic toxin type A produced by Streptococcus pyogenes strain NY-5 cultured in the synthetic medium NCTC-135. Comparison with the dialyzed medium (TP medium)-derived toxin. Microbiol Immunol. 1989;33(3):183–194. doi: 10.1111/j.1348-0421.1989.tb01512.x. [DOI] [PubMed] [Google Scholar]
  24. Kappler J., Kotzin B., Herron L., Gelfand E. W., Bigler R. D., Boylston A., Carrel S., Posnett D. N., Choi Y., Marrack P. V beta-specific stimulation of human T cells by staphylococcal toxins. Science. 1989 May 19;244(4906):811–813. doi: 10.1126/science.2524876. [DOI] [PubMed] [Google Scholar]
  25. Kapur V., Majesky M. W., Li L. L., Black R. A., Musser J. M. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7676–7680. doi: 10.1073/pnas.90.16.7676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Keene W. E., Petitt M. G., Allen S., McKerrow J. H. The major neutral proteinase of Entamoeba histolytica. J Exp Med. 1986 Mar 1;163(3):536–549. doi: 10.1084/jem.163.3.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kim Y. B., Watson D. W. A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J Exp Med. 1970 Mar 1;131(3):611–622. doi: 10.1084/jem.131.3.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kline J. B., Collins C. M. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun. 1996 Mar;64(3):861–869. doi: 10.1128/iai.64.3.861-869.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kreiswirth B. N., Handley J. P., Schlievert P. M., Novick R. P. Cloning and expression of streptococcal pyrogenic exotoxin A and staphylococcal toxic shock syndrome toxin-1 in Bacillus subtilis. Mol Gen Genet. 1987 Jun;208(1-2):84–87. doi: 10.1007/BF00330426. [DOI] [PubMed] [Google Scholar]
  30. Kum W. W., Laupland K. B., See R. H., Chow A. W. Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1. J Clin Microbiol. 1993 Oct;31(10):2654–2660. doi: 10.1128/jcm.31.10.2654-2660.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Köhler W. Streptococcal toxic shock syndrome. Zentralbl Bakteriol. 1990 Mar;272(3):257–264. doi: 10.1016/s0934-8840(11)80026-5. [DOI] [PubMed] [Google Scholar]
  32. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  33. Landt O., Grunert H. P., Hahn U. A general method for rapid site-directed mutagenesis using the polymerase chain reaction. Gene. 1990 Nov 30;96(1):125–128. doi: 10.1016/0378-1119(90)90351-q. [DOI] [PubMed] [Google Scholar]
  34. Landt O., Zirpel-Giesebrecht M., Milde A., Hahn U. Improving purification of recombinant ribonuclease T1. J Biotechnol. 1992 Jun;24(2):189–194. doi: 10.1016/0168-1656(92)90122-p. [DOI] [PubMed] [Google Scholar]
  35. Leonard B. A., Lee P. K., Jenkins M. K., Schlievert P. M. Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity. Infect Immun. 1991 Mar;59(3):1210–1214. doi: 10.1128/iai.59.3.1210-1214.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  37. Mazzei D., Novi C., Bazzi C. Mitogenic action of papain. Lancet. 1966 Oct 8;2(7467):802–803. doi: 10.1016/s0140-6736(66)90406-5. [DOI] [PubMed] [Google Scholar]
  38. Mazzei D., Novi C., Bazzi C. Mitogenic action of trypsin and chymotrypsin. Lancet. 1966 Jul 23;2(7456):232–232. doi: 10.1016/s0140-6736(66)92526-8. [DOI] [PubMed] [Google Scholar]
  39. Movva N. R., Nakamura K., Inouye M. Amino acid sequence of the signal peptide of ompA protein, a major outer membrane protein of Escherichia coli. J Biol Chem. 1980 Jan 10;255(1):27–29. [PubMed] [Google Scholar]
  40. Musser J. M., Hauser A. R., Kim M. H., Schlievert P. M., Nelson K., Selander R. K. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668–2672. doi: 10.1073/pnas.88.7.2668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ohara-Nemoto Y., Sasaki M., Kaneko M., Nemoto T., Ota M. Cysteine protease activity of streptococcal pyrogenic exotoxin B. Can J Microbiol. 1994 Nov;40(11):930–936. doi: 10.1139/m94-149. [DOI] [PubMed] [Google Scholar]
  42. Pinkney M., Kapur V., Smith J., Weller U., Palmer M., Glanville M., Messner M., Musser J. M., Bhakdi S., Kehoe M. A. Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease. Infect Immun. 1995 Jul;63(7):2776–2779. doi: 10.1128/iai.63.7.2776-2779.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schober I., Braun R., Reiser H., Munk K., Leroux M., Kirchner H. la-positive T lymphocytes are the producer cells of interferon gamma. Exp Cell Res. 1984 Jun;152(2):348–356. doi: 10.1016/0014-4827(84)90636-0. [DOI] [PubMed] [Google Scholar]
  44. Sreerama N., Woody R. W. Protein secondary structure from circular dichroism spectroscopy. Combining variable selection principle and cluster analysis with neural network, ridge regression and self-consistent methods. J Mol Biol. 1994 Sep 30;242(4):497–507. doi: 10.1006/jmbi.1994.1597. [DOI] [PubMed] [Google Scholar]
  45. Stevens D. L., Tanner M. H., Winship J., Swarts R., Ries K. M., Schlievert P. M., Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989 Jul 6;321(1):1–7. doi: 10.1056/NEJM198907063210101. [DOI] [PubMed] [Google Scholar]
  46. Swaminathan S., Furey W., Pletcher J., Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 1992 Oct 29;359(6398):801–806. doi: 10.1038/359801a0. [DOI] [PubMed] [Google Scholar]
  47. Teng N. N., Bo Chen L. The role of surface proteins in cell proliferation as studied with thrombin and other proteases. Proc Natl Acad Sci U S A. 1975 Feb;72(2):413–417. doi: 10.1073/pnas.72.2.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tomai M. A., Schlievert P. M., Kotb M. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun. 1992 Feb;60(2):701–705. doi: 10.1128/iai.60.2.701-705.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Weeks C. R., Ferretti J. J. Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12. Infect Immun. 1986 Apr;52(1):144–150. doi: 10.1128/iai.52.1.144-150.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Weeks C. R., Ferretti J. J. The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12. Infect Immun. 1984 Nov;46(2):531–536. doi: 10.1128/iai.46.2.531-536.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yamamoto M., Ferretti J. J. High level expression of Streptococcus pyogenes erythrogenic toxin A (SPE A) in Escherichia coli and its rapid purification by HPLC. FEMS Microbiol Lett. 1995 Oct 15;132(3):209–213. doi: 10.1111/j.1574-6968.1995.tb07835.x. [DOI] [PubMed] [Google Scholar]
  53. Yang J. T., Bewley T. A., Chen G. C., Li C. H. Conformation of beta-endorphin and beta-lipotropin: formation of helical structure in methanol and sodium dodecyl sulfate solutions. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3235–3238. doi: 10.1073/pnas.74.8.3235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Yu C. E., Ferretti J. J. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun. 1989 Dec;57(12):3715–3719. doi: 10.1128/iai.57.12.3715-3719.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES